GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BTG PLC (OTCPK:BTGGF) » Definitions » 12-1 Month Momentum %

BTG (BTGGF) 12-1 Month Momentum % : 52.91% (As of Apr. 28, 2024)


View and export this data going back to . Start your Free Trial

What is BTG 12-1 Month Momentum %?

12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2024-04-28), BTG's 12-1 Month Momentum % is 52.91%.

The industry rank for BTG's 12-1 Month Momentum % or its related term are showing as below:

BTGGF's 12-1 Month Momentum % is not ranked
in the Biotechnology industry.
Industry Median: -20.83 vs BTGGF: 52.91

Competitive Comparison of BTG's 12-1 Month Momentum %

For the Biotechnology subindustry, BTG's 12-1 Month Momentum %, along with its competitors' market caps and 12-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BTG's 12-1 Month Momentum % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BTG's 12-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where BTG's 12-1 Month Momentum % falls into.



BTG  (OTCPK:BTGGF) 12-1 Month Momentum % Calculation

12-1 Month Momentum % is calculated as following:

12-1 Month Momentum %=( Price 1-month ago / Price 12-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


BTG  (OTCPK:BTGGF) 12-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.


BTG 12-1 Month Momentum % Related Terms

Thank you for viewing the detailed overview of BTG's 12-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.


BTG (BTGGF) Business Description

Traded in Other Exchanges
N/A
Address
5 Fleet Place, London, GBR, EC4M 7RD
BTG is a biotechnology company that develops products in specialty areas of medicine. The company's three operating segments are interventional medicine, specialty pharmaceuticals, and licensing. Its interventional medicine focuses on oncology, vascular treatments, and pulmonology. BTG's revenue is roughly split between these three segments, while its oncology operations lead the interventional segment. The company has been known to utilize acquisitions for investing in leading therapies and capabilities.